Brief: Microtech Medical Hangzhou Says NMPA Approved Registration Of Drug For Marketing
05/11/2021 02:00
Nov 5 (Reuters) - MicroTech Medical Hangzhou Co Ltd
2235.HK :
* NMPA APPROVED REGISTRATION OF "CONTINUOUS GLUCOSE
MONITORING
SYSTEM" FOR MARKETING
Further company coverage: 2235.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MicroTech Medical (Hangzhou)
See all newsBrief: MicroTech Medical (Hangzhou) Says AIDEX G9 Receives Marketing Approval From NMPA China
Brief: Microtech Medical (Hangzhou) Receives Marketing Approval In South Korea For Linx Glucose Monitoring System
Advisory: Alert incorrectly tagged to MicroTech Medical withdrawn
Brief: Microtech Medical (Hangzhou) Says Linx Continuous Glucose Monitoring System Received Market Approval In Brazil
Brief: Microtech Medical (Hangzhou) Says Linx System Received Market Approval In India